I-Mab ADR (IMAB) Social Stream



I-Mab ADR (IMAB): $0.92

0.03 (-3.17%)

POWR Rating

Get Rating

Component Grades

Growth

Get Rating

Value

Get Rating

Momentum

D

Stability

C

Sentiment

Get Rating

Quality

D

Add IMAB to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#68 of 151

in industry
See All 'A' Rated Buy Stocks

Featured Post From StockTwits About IMAB

$IMAB NEW ARTICLE : I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab (TJM2) to Treat Patients with Severe COVID-19 https://www.stck.pro/news/IMAB/14862068
STCKPRO, published August 11, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!